Compare ETFs: IBB vs. LON:HEAL
IBB
LON:HEAL
Comparison
Average Return
In the past year, IBB returned a total of 48.40%, which is significantly higher than LON:HEAL's 34.39% return. Over the past 10 years, IBB has had annualized average returns of 8.02%, compared to 7.70% for LON:HEAL. These numbers are adjusted for stock splits and assume dividends are reinvested.
Top 25 Holdings
| IBB - iShares Biotechnology ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | GILD | Gilead Sciences, Inc. | 8.16% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 7.65% |
| 3 | AMGN | Amgen Inc. | 7.53% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 5.57% |
| 5 | MRNA | Moderna, Inc. | 5.02% |
| 6 | NTRA | Natera, Inc. | 3.88% |
| 7 | ARGX | argenx SE | 3.77% |
| 8 | ILMN | Illumina, Inc. | 2.91% |
| 9 | RVMD | Revolution Medicines, Inc. | 2.72% |
| 10 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.35% |
| 11 | BIIB | Biogen Inc. | 2.34% |
| 12 | ONC | BeOne Medicines AG | 2.14% |
| 13 | INSM | Insmed Incorporated | 1.85% |
| 14 | INCY | Incyte Corporation | 1.77% |
| 15 | UTHR | United Therapeutics Corporation | 1.38% |
| 16 | GMAB | Genmab A/S | 1.36% |
| 17 | ROIV | Roivant Sciences Ltd. | 1.34% |
| 18 | ASND | Ascendis Pharma A/S | 1.00% |
| 19 | NBIX | Neurocrine Biosciences, Inc. | 0.99% |
| 20 | MEDP | Medpace Holdings, Inc. | 0.98% |
| 21 | EXEL | Exelixis, Inc. | 0.98% |
| 22 | CRL | Charles River Laboratories International, Inc. | 0.98% |
| 23 | HALO | Halozyme Therapeutics, Inc. | 0.91% |
| 24 | TWST | Twist Bioscience Corporation | 0.83% |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 0.83% |
| View IBB holdings | |||
| LON:HEAL - iShares Healthcare Innovation UCITS ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | MRNA | Moderna, Inc. | 4.96% |
| 2 | NTRA | Natera, Inc. | 2.24% |
| 3 | ILMN | Illumina, Inc. | 2.08% |
| 4 | IQV | IQVIA Holdings Inc. | 1.79% |
| 5 | RVTY | Revvity, Inc. | 1.71% |
| 6 | CPH: GMAB | Genmab A/S | 1.68% |
| 7 | GH | Guardant Health, Inc. | 1.65% |
| 8 | A | Agilent Technologies, Inc. | 1.55% |
| 9 | ROIV | Roivant Sciences Ltd. | 1.51% |
| 10 | MRK | Merck & Co., Inc. | 1.50% |
| 11 | MEDP | Medpace Holdings, Inc. | 1.49% |
| 12 | GILD | Gilead Sciences, Inc. | 1.45% |
| 13 | DHR | Danaher Corporation | 1.44% |
| 14 | CRL | Charles River Laboratories International, Inc. | 1.43% |
| 15 | AMGN | Amgen Inc. | 1.43% |
| 16 | ABBV | AbbVie Inc. | 1.43% |
| 17 | KRX: 068270 | Celltrion, Inc. | 1.40% |
| 18 | JNJ | Johnson & Johnson | 1.39% |
| 19 | HALO | Halozyme Therapeutics, Inc. | 1.39% |
| 20 | BIIB | Biogen Inc. | 1.38% |
| 21 | DXCM | DexCom, Inc. | 1.36% |
| 22 | ABT | Abbott Laboratories | 1.35% |
| 23 | PFE | Pfizer Inc. | 1.34% |
| 24 | SWX: LONN | Lonza Group AG | 1.34% |
| 25 | EXEL | Exelixis, Inc. | 1.33% |
| View LON:HEAL holdings | |||